Completed Studies

The following studies are completed. Use the links in the box on the left for information on each of the completed studies conducted by the PASA Consortium. 

AS140026-A1 Howard Becker, Ph.D.


Study Type: Preclinical Study
Protocol: Preclinical Analysis of Combined Carisbamate and Doxazosin Treatments in Stress-Alcohol Drinking Models
Participating Site: Medical University of South Carolina (MUSC)

 

AS140026-A2 Colin Haile, M.D., Ph.D.


Study Type: Preclinical Study
Protocol: Assessing Pharmacotherapies in Animal Models of PTSD and AUD
Participating Site: Baylor College of Medicine (BCM)

 

AS140026-A4 Christopher Verrico, Ph.D.


Study Type:  Phase II Clinical Trial
Protocol: Zonisamide as a New Treatment for Co-occurring Post-Traumatic Stress-Disorder (PTSD) and Alcohol Use Disorder (AUD)  
Participating Site: Michael E. Debakey Veterans Affairs Medical Center (MEDVAMC)

 

AS140026-A7 Steven L. Batki, M.D.


Study Type:  Phase II Clinical Trial
Protocol: N-acetylcysteine Treatment to Reduce Alcohol Use, Cognitive Impairment and PTSD Symptom Severity in Veterans with Traumatic Brain Injury and Alcohol Use Disorder: A Confirmatory Study 
Participating Site: TBA

 

AS140026-A3b Christopher Verrico, Ph.D., Dewleen Baker, M.D., and Thomas Kosten, M.D.


Study Type: Phase I Clinical Trial
Protocol: PT150 (formerly ORG 34517) as a Potential Treatment for Alcohol Dependence – Alcohol Interaction Study
Participating Site: Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC)

 

AS170014-A1 Colin N Haile, M.D., Ph.D.


Study Type: Preclinical Study
Protocol: Novel Strategies for the Treatment of Opioid Use Disorder and Post-Traumatic Stress Disorder: Anti-Fentanyl Vaccine and Buprenorphine Combination Therapy
Participating Site: Baylor College of Medicine (BCM)

 

AS170014-A2 Michael T. Bardo, Ph.D.


Study Type: Preclinical Study
Protocol: Preclinical assessment of PT-150 for opioid use disorder and PTSD
Participating Site: University of Kentucky